Magnokal

Potassium hydrogen aspartate, the active ingredient in Magnokal, is a electrolyte supplement presented as an oral tablet for oral use. It helps correct potassium and magnesium deficiencies and supports electrolyte balance in adults.

GNH USA supplies Magnokal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Magnokal is used to address electrolyte disturbances and related conditions. - Potassium deficiency: helps restore normal potassium levels. - Magnesium deficiency: contributes to re‑establishing adequate magnesium status. - Electrolyte imbalance: supports overall electrolyte homeostasis. - Muscle cramps: may reduce the frequency and intensity of cramp episodes.

Adverse reactions may occur with oral electrolyte supplements.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Abdominal discomfort: transient cramping or fullness. - Diarrhea: loose stools in some individuals. - Headache: occasional mild headache.

Serious or Rare Side Effects: - Hyperkalemia: elevated blood potassium that can affect heart rhythm. - Hypermagnesemia: excess magnesium leading to muscle weakness or cardiac effects. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Cardiac arrhythmia: irregular heartbeat in susceptible patients. - Respiratory depression: rare but serious breathing difficulty.

When using Magnokal, consider the following safety measures. - Renal impairment: monitor potassium and magnesium levels closely. - Cardiac disease: use with caution due to electrolyte effects on heart rhythm. - Concurrent diuretics: assess electrolyte status regularly. - Pregnancy and breastfeeding: safety not established; consult a healthcare professional. - Drug interactions: review all concomitant medications. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Magnokal may interact with other medicines that affect electrolyte balance.

Major Interactions (Avoid): - ACE inhibitors: increased risk of hyperkalemia. - Potassium‑sparing diuretics: may cause excessive potassium accumulation.

Moderate Interactions (Monitor Closely): - Loop diuretics: may alter magnesium levels. - Digoxin: electrolyte shifts can affect drug toxicity. - Certain antibiotics (e.g., aminoglycosides): renal function changes may modify electrolyte handling.